Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Iberogast combines several herbal extracts that exert spasmolytic, pro‑kinetic, anti‑inflammatory and mucosal‑protective actions. Together they relax smooth muscle, stimulate normal peristalsis, reduce inflammatory mediators and protect the gastrointestinal lining, supporting overall digestive function.

The dose of Iberogast is determined by the prescribing healthcare professional. Typical regimens are based on the patient’s age, weight and severity of symptoms, and the prescriber will provide specific instructions on the number of drops and frequency.

Safety data for Iberogast in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless clearly indicated by a physician, and breastfeeding mothers should consult their healthcare provider before starting treatment.

To order Iberogast, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with conventional antispasmodics or fibre supplements, Iberogast offers a multi‑target herbal approach that combines spasmolytic, pro‑kinetic and anti‑inflammatory effects. Clinical experience suggests it may provide symptom relief with a favorable safety profile, though individual response can vary.

Iberogast should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from direct sunlight, moisture and extreme heat, and store it in its original packaging to maintain product stability.

Iberogast is supplied as an oral liquid (drops). The prescribed number of drops is taken directly onto the tongue or mixed with a small amount of water, usually before or after meals as directed by the prescriber.

Serious risks, although rare, include allergic reactions such as rash, urticaria or anaphylaxis, and potential liver enzyme elevations that may indicate hepatic injury. Patients should seek immediate medical attention if they experience signs of severe allergy or liver dysfunction.

Iberogast should not be used by children under 12 years of age, individuals with known hypersensitivity to any of its herbal components, or patients with severe liver disease without close monitoring. Pregnant or breastfeeding women should only use it under medical supervision.